Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW. Brian Dalton, Josh Lauring, Patrick M. Forde et al.|JCO Precision Oncology|2017Cited by 95
Abstract CT264: Mutant KRAS peptide vaccine combined with ipilimumab/nivolumab in advanced mismatch repair proficient/microsatellite stable (MMRp/MSS) colorectal cancer: Preliminary analysis from a phase I studyHejia Wang, Neeha Zaidi, Amanda L. Huff et al.|Cancer Research|2025Cited by 3
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and GuidelinesSuzanne Russo, Dmitriy Akselrod, Christopher L. Hallemeier et al.|Cancer Medicine|2025Cited by 1